Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort

Chew, Christine; Reynolds, John; Lertratanakul, Apinya; Wu, Peggy; Urowitz, Murray; Gladman, Dafna; Fortin, Paul; Bae, Sang-Cheol; Gordon, Caroline; Clarke, Ann; Bernatsky, Sasha; Hanly, John; Isenberg, David; Rahman, Anisur; Sanchez-Guerrero, Jorge; Romero-Diaz, Juanita; Merrill, Joan; Wallace, Daniel; Ginzler, Ellen; Khamashta, Munther; Nived, Ola; Jonsen, Andreas; Steinsson, Kristjan; Manzi, Susan; Kalunian, Ken; Dooley, Mary; Petri, Michelle; Aranow, Cynthia; van Vollenhoven, Ronald; Stoll, Thomas; Alarcon, Graciela; Lim, S.; Ruiz-Irastorza, Guillermo; Peschken, Christine; Askanase, Anca; Kamen, Diane; Inanc, MURAT; Ramsey-Goldman, Rosalind; Bruce, Ian

doi:10.1093/rheumatology/keab090

Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort

Chew C., Reynolds J. A., Lertratanakul A., Wu P., Urowitz M., Gladman D. D., ...Daha Fazla

RHEUMATOLOGY, cilt.60, sa.10, ss.4737-4747, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 60 Sayı: 10
Basım Tarihi: 2021
Doi Numarası: 10.1093/rheumatology/keab090
Dergi Adı: RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
Sayfa Sayıları: ss.4737-4747
Anahtar Kelimeler: systemic lupus erythematosus, vitamin D, cardiovascular disease, epidemiology, 25-HYDROXYVITAMIN D DEFICIENCY, CARDIOVASCULAR RISK-FACTORS, LOW-DENSITY-LIPOPROTEIN, 3RD NATIONAL-HEALTH, ERYTHEMATOSUS DATA, DISEASE-ACTIVITY, INDEPENDENT ASSOCIATION, WOMEN, PREVALENCE, 1,25-DIHYDROXYVITAMIN-D
İstanbul Üniversitesi Adresli: Evet

Özet

Objectives. Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance.